Thursday, February 3, 2011

Antiemetics: Technologies and Global Markets


Antiemetics: Technologies and Global Markets

The global market for antiemetics was nearly $2.4 billion in 2009. There was a little setback seen in 2009 in the 5-HT3 category due to weakened economy and competition within brands and generics. The market for antiemetic products is expected to reach $2.5 billion by the end of 2010 and $3.6 billion by 2015, reflecting a 7.4% compound annual growth rate (CAGR).
Although 5-HT3 antagonists have seen a decline in 2009, this category holds about half of the market. This sector is valued at an estimated $1 billion in 2010 and is expected to increase at a 3.6% compound annual growth rate (CAGR) between 2010 and 2015 to reach $1.3 billion in 2015.
NK1 receptor and dopamine antagonist and anticholinergics will experience the most growth over the forecast period. This sector is worth an estimated $582 million in 2010 and is expected to reach more than $1 billion by 2015, a 13.3% compound annual growth rate (CAGR).
INTRODUCTION
STUDY OBJECTIVES
BCC’s goal in conducting this study is to provide an overview of the current and future characteristics of the global market for antiemetic agents. The key objective is to present a comprehensive analysis of the current market and its future direction and the antiemetics market as an important agent as adjunct therapy for cancer patients and also other therapeutic arenas to control emesis.
This report explores present and future strategies within the antiemetic market, reason for emesis, and types of antiemetic agents used to control nausea or vomiting. The improvisation of the market, and the setbacks and the needs of the market are discussed in this report. The causes of emesis, usage of antiemetics and the types of products available to treat nausea and vomiting of each category of antiemetics are also portrayed in this report.
A detailed analysis of the antiemetic industry structure has been conducted. The revenues are broken down by region. Sales figures are estimated for the 5 year period from the end of 2010 through 2015.
Applications for antiemetics are also discussed separately in the report, with emphasis on the usage in chemotherapy-induced nausea and vomiting (CINV), post-radiotherapy nausea and vomiting, and post-operative nausea and vomiting (PONV), etc. The report also covers significant patents and their allotments in each category.

REASONS FOR DOING THIS STUDY
Emesis itself is not a disease but is stressful enough to discourage a patient, especially a patient dealing with cancer therapies. The antiemetics market has seen advancement in modern medicine. R&D spending, along with increasing competition, patent expiries, new technologies, and an international marketplace are directing this new direction. The antiemetics market has seen almost a constant growth except some setbacks in 5-HT2 category in 2009, due to the general economic downturn, but new advances and the need for good pharmacological activity of antiemetic products are influencing the market to grow. This study looks at almost all the systems affected by these factors.
Acquisition strategies and collaborations by companies are also covered in this report. This study also discusses the strength and weaknesses of each system/ technology in light of the new technologies, growing competition, and changing customer needs.
INTENDED AUDIENCE
This study contributes to the areas of market growth in the antiemetic industry from the point of view of manufacturers and users. Biotechnological companies, physicians, the pharmaceutical and biopharmaceutical industries, hospitals, and research institutes will find this study to be of interest.
SCOPE OF THE STUDY
The scope of this study encompasses the biotechnology, pharmaceutical, and medical markets. BCC analyzes each market and its applications by its need for development of new medications, regulatory environment, technology involved, market projections, and market share. Technological issues include the latest trends and developments.
METHODOLOGY
Both primary and secondary research methodologies were used in preparing this market research report. BCC conducted a comprehensive search of the literature, which included technical newsletters and journals, and many other sources. Data were collected through interviews and correspondence with various analytical/chemical/pharmaceutical/biotechnical experts. Projections were based on estimates such as the current number of end users, potential end users, mergers and acquisitions, and market trends.
Buy Now: Market Research

Related Reports

at